Literature DB >> 30267310

Small Molecule Modifiers of In Vitro Manganese Transport Alter Toxicity In Vivo.

Tanara V Peres1, Kyle J Horning2, Julia Bornhorst3, Tanja Schwerdtle3, Aaron B Bowman2,4, Michael Aschner5.   

Abstract

Manganese (Mn) is essential for several species and daily requirements are commonly met by an adequate diet. Mn overload may cause motor and psychiatric disturbances and may arise from an impaired or not fully developed excretion system, transporter malfunction and/or exposure to excessive levels of Mn. Therefore, deciphering processes regulating neuronal Mn homeostasis is essential to understand the mechanisms of Mn neurotoxicity. In the present study, we selected two small molecules (with opposing effects on Mn transport) from a previous high throughput screen of 40,167 to test their effects on Mn toxicity parameters in vivo using Caenorhabditis elegans. We pre-exposed worms to VU0063088 and VU0026921 for 30 min followed by co-exposure for 1 h with Mn and evaluated Mn accumulation, dopaminergic (DAergic) degeneration and worm survival. Control worms were exposed to vehicle (DMSO) and saline only. In pdat-1::GFP worms, with GFP labeled DAergic neurons, we observed a decrease of Mn-induced DAergic degeneration in the presence of both small molecules. This effect was also observed in an smf-2 knockout strain. SMF-2 is a regulator of Mn transport in the worms and this strain accumulates higher Mn levels. We did not observe improved survival in the presence of small molecules. Our results suggest that both VU0063088 and VU0026921 may modulate Mn levels in the worms through a mechanism that does not require SMF-2 and induce protection against Mn neurotoxicity.

Entities:  

Keywords:  C. elegans; Dopamine; Manganese; Neurotoxicity; Small molecules

Mesh:

Substances:

Year:  2018        PMID: 30267310      PMCID: PMC6438193          DOI: 10.1007/s12011-018-1531-7

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  23 in total

Review 1.  Brain magnetic resonance imaging and manganese exposure.

Authors:  R Lucchini; E Albini; D Placidi; R Gasparotti; M G Pigozzi; G Montani; L Alessio
Journal:  Neurotoxicology       Date:  2000-10       Impact factor: 4.294

Review 2.  Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination.

Authors:  Jerome A Roth
Journal:  Biol Res       Date:  2006       Impact factor: 5.612

3.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.

Authors:  Karin Tuschl; Peter T Clayton; Sidney M Gospe; Shamshad Gulab; Shahnaz Ibrahim; Pratibha Singhi; Roosy Aulakh; Reinaldo T Ribeiro; Orlando G Barsottini; Maha S Zaki; Maria Luz Del Rosario; Sarah Dyack; Victoria Price; Andrea Rideout; Kevin Gordon; Ron A Wevers; W K Kling Chong; Philippa B Mills
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

4.  C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway.

Authors:  E R Sawin; R Ranganathan; H R Horvitz
Journal:  Neuron       Date:  2000-06       Impact factor: 17.173

5.  Lifespan extension in Caenorhabditis elegans by DMSO is dependent on sir-2.1 and daf-16.

Authors:  Xiangming Wang; Xiaoyan Wang; Lianda Li; Danqiao Wang
Journal:  Biochem Biophys Res Commun       Date:  2010-09-07       Impact factor: 3.575

6.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

7.  Effect of levodopa treatment for parkinsonism in welders: A double-blind study.

Authors:  William C Koller; Kelly E Lyons; William Truly
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

8.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder.

Authors:  Karin Tuschl; Philippa B Mills; Howard Parsons; Marian Malone; Darren Fowler; Maria Bitner-Glindzicz; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

9.  A Parkinsonian syndrome in methcathinone users and the role of manganese.

Authors:  Ainārs Stepens; Ināra Logina; Viesturs Liguts; Pauls Aldins; Ilze Eksteina; Ardis Platkājis; Inese Mārtinsone; Elmārs Tērauds; Baiba Rozentāle; Michael Donaghy
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245

10.  SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans.

Authors:  Catherine Au; Alexandre Benedetto; Joel Anderson; Arnaud Labrousse; Keith Erikson; Jonathan J Ewbank; Michael Aschner
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more
  2 in total

Review 1.  Manganese-induced neurodegenerative diseases and possible therapeutic approaches.

Authors:  Airton C Martins; Priscila Gubert; Gustavo R Villas Boas; Marina Meirelles Paes; Abel Santamaría; Eunsook Lee; Alexey A Tinkov; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2020-09-02       Impact factor: 4.618

2.  Identification of Three Small Molecules That Can Selectively Influence Cellular Manganese Levels in a Mouse Striatal Cell Model.

Authors:  Kyle J Horning; Xueqi Tang; Morgan G Thomas; Michael Aschner; Aaron B Bowman
Journal:  Molecules       Date:  2021-02-22       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.